FTO suppresses cardiac fibrosis after myocardial infarction via m6A-mediated epigenetic modification
Ontology highlight
ABSTRACT: Cardiac fibrosis is common in cardiovascular diseases. N6-methyladenosine (m6A) is one of the most common modifications in eukaryotic mRNAs. Previous research has suggested that m6A modification is vital in cardiovascular diseases. The underlying targets of FTO were selected through transcriptome sequencing (RNA-seq) combined with methylated RNA immunoprecipitation sequencing (MeRIP-seq). According to MeRIP-seq and RNA-seq, FTO inhibited collagen synthesis in CFs.
ORGANISM(S): Rattus norvegicus
PROVIDER: GSE257546 | GEO | 2024/03/01
REPOSITORIES: GEO
ACCESS DATA